CV Sciences, Inc. Scheduled to Announce First Quarter 2026 Financial Results
CV Sciences, Inc. will announce its first quarter 2026 financial results post-market on May 14, 2026, along with a conference call scheduled for the same day.
Topic Intelligence
Articles and insights tagged Non-fungible Token (NFT) on FAQSIR.
CV Sciences, Inc. will announce its first quarter 2026 financial results post-market on May 14, 2026, along with a conference call scheduled for the same day.
Stemtech Corporation announces the appointment of Dr. Lizette Leos, MD, as Chief Scientific Officer, enhancing its focus on scientific validation and international expansion.
Cypher Metaverse Inc. has entered a definitive agreement to acquire Noninvasix, strengthening its portfolio in the medical technology space and preparing for public listing.
Cypher Metaverse Inc. has issued its fifth Default Status Report, outlining continued delays in financial filings and implications for its securities. The company intends to meet its obligations promptly.
Grid Metals Corp. will participate in THE Mining Investment Event from June 3-5, showcasing projects in Manitoba and appointing a cesium industry expert amid ongoing wildfire issues.
Cypher Metaverse Inc. has announced further delays in its financial filings amid ongoing audit processes, with commitments to regular updates to maintain transparency for investors.
Avant Technologies and Ainnova Tech are beginning to design a clinical trial for their Vision AI platform, which focuses on the early detection of diabetic retinopathy. A pre-submission meeting with the FDA is anticipated for May 2025.